Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Harnessing the Stem Cell Niche in Regenerative Medicine: Innovative Avenue to Combat Neurodegenerative Diseases
Gordana Velikić, D Marić, Dušica Marić, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 993-993
Open Access | Times Cited: 16
The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application
Juan P. Muñoz, Pablo Ernesto Pérez, Yasmín P. Pérez, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3072-3072
Open Access | Times Cited: 28
The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases
Samar F. Darwish, Abdullah M. M. Elbadry, Amir S. Elbokhomy, et al.
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 25
Midbrain organoids for Parkinson's disease (PD) - A powerful tool to understand the disease pathogenesis
Harysh Winster Suresh Babu, Sindduja Muthu Kumar, Harsimrat Kaur, et al.
Life Sciences (2024) Vol. 345, pp. 122610-122610
Closed Access | Times Cited: 9
Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases
Raya Kh. Yashooa, Elisa Duranti, Donatella Conconi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 626-626
Open Access | Times Cited: 1
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Junhan Liang, Zhirong Wan, Cheng Qian, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
MicroRNAs: a symphony orchestrating evolution and disease dynamics
Shan Quah, Gowtham Subramanian, Jonathan S.L. Tan, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 6
The dysregulation of miRNAs in epilepsy and their regulatory role in inflammation and apoptosis
Guoping Xie, Huan Chen, Chan He, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Open Access | Times Cited: 14
MicroRNA (miRNA) Complexity in Alzheimer’s Disease (AD)
Walter J. Lukiw
Biology (2023) Vol. 12, Iss. 6, pp. 788-788
Open Access | Times Cited: 13
Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer’s Disease
Chunxiang He, Ze Li, Miao Yang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 4165-4211
Open Access | Times Cited: 13
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review
Hafiz Muhammad Husnain Azam, Rosa Rößling, Christiane Geithe, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease
Reda Mansour, A. A. Shaker, Ahmed I. Abulsoud, et al.
Molecular Neurobiology (2025)
Closed Access
Cytoskeletal alterations in neuronal cells implicate Toxoplasma gondii secretory machinery and host microRNA-containing extracellular vesicles
Tommaso Mazza, Morteza Aslanzadeh, Lïse Berentsen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
miRNA in Parkinson's disease: From pathogenesis to theranostic approaches
Ajay Elangovan, Dhivya Venkatesan, Priyanka Selvaraj, et al.
Journal of Cellular Physiology (2022) Vol. 238, Iss. 2, pp. 329-354
Closed Access | Times Cited: 20
Luteolin/ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA‐124 by targeting C/EBPA
Enas M. Moustafa, Fatma SM Moawed, Dina F. El-Maghraby
Environmental Toxicology (2023) Vol. 38, Iss. 11, pp. 2691-2704
Open Access | Times Cited: 9
Circulating microRNA miR-425-5p Associated with Brain White Matter Lesions and Inflammatory Processes
Sandra Van der Auwera, Sabine Ameling, Katharina Wittfeld, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 887-887
Open Access | Times Cited: 3
miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson’s disease models
Xiang Tao, Wenfei Zhang, Chen Chen, et al.
Aging (2024) Vol. 16, Iss. 10, pp. 8732-8746
Open Access | Times Cited: 3
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study
Simone Detassis, Francesca Precazzini, Margherita Grasso, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5573-5573
Open Access | Times Cited: 3
The Beneficial Effects of Lacticaseibacillus paracasei subsp. paracasei DSM 27449 in a Letrozole-Induced Polycystic Ovary Syndrome Rat Model
Yan Zhang Lee, Shih-Hsuan Cheng, Yufen Lin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8706-8706
Open Access | Times Cited: 3
MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS
Ya‐Ling Yang, Tsu‐Kung Lin, Ying‐Hsien Huang
European Journal of Pharmacology (2022) Vol. 934, pp. 175302-175302
Open Access | Times Cited: 15
Heavy metals toxicity on epigenetic modifications in the pathogenesis of Alzheimer's disease (AD)
Dhivya Venkatesan, Sindduja Muthukumar, Mahalaxmi Iyer, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 2
Potential application of aptamers combined with DNA nanoflowers in neurodegenerative diseases
Zhongci Hang, Liping Zhou, Xiaochun Bian, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102444-102444
Closed Access | Times Cited: 2
Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases
Ling Wang, Xiaoyan Zhang, Ziyi Yang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Detection of a Parkinson's Disease–Specific MicroRNA Signature in Nasal and Oral Swabs
Patricia Schließer, Felix L. Struebing, Bernd H. Northoff, et al.
Movement Disorders (2023) Vol. 38, Iss. 9, pp. 1706-1715
Open Access | Times Cited: 6
Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson’s Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway
Ru‐Huei Fu, Chia-Wen Tsai, Shih‐Ping Liu, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2089-2089
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top